PMV Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:PMVP Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Role	Shares	Max Price
11 Sep 24	SellUS$10,853	Deepika Jalota	Individual		7,218	US$1.50
11 Sep 24	SellUS$4,347	Michael Carulli	Individual		2,891	US$1.50

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of PMVP?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	1,250,521	2.41%
VC/PE Firms	6,475,291	12.5%
Hedge Funds	9,637,678	18.6%
General Public	11,098,682	21.4%
Institutions	23,471,432	45.2%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 72.12% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
12.5%	OrbiMed Advisors LLC	6,475,291	US$8.2m	0%	0.13%
6.88%	Sio Capital Management, LLC	3,572,167	US$4.5m	11.1%	1.49%
6.76%	ArrowMark Colorado Holdings, LLC	3,508,451	US$4.5m	-3.81%	0.06%
6.68%	BML Capital Management, LLC	3,466,684	US$4.4m	105%	2.7%
5.06%	Euclidean Capital LLC	2,627,643	US$3.3m	0%	0.47%
5%	PFM Health Sciences, LP	2,598,827	US$3.3m	25%	0.25%
4.13%	The Vanguard Group, Inc.	2,143,102	US$2.7m	-6.04%	no data
4%	Acadian Asset Management LLC	2,078,866	US$2.6m	0%	0.01%
3.78%	Alkeon Capital Management, LLC	1,963,132	US$2.5m	0%	0.02%
2.21%	BlackRock, Inc.	1,146,484	US$1.5m	0.15%	no data
1.97%	D. E. Shaw & Co., L.P.	1,024,288	US$1.3m	-1.56%	no data
1.51%	David Mack	785,326	US$997.4k	21.1%	no data
1.38%	Two Sigma Advisers, LP	714,600	US$907.5k	-4.87%	no data
1.04%	Jacobs Levy Equity Management Inc	539,893	US$685.7k	-23.5%	no data
1.03%	Stonepine Capital Management LLC	535,805	US$680.5k	0%	0.29%
0.99%	Citigroup Inc.,Banking and Securities Investments	514,911	US$653.9k	0%	no data
0.98%	Two Sigma Investments, LP	506,986	US$643.9k	4.95%	no data
0.97%	Aldebaran Capital, LLC	502,190	US$637.8k	14.6%	0.61%
0.86%	Peapod Lane Capital LLC	445,744	US$566.1k	0%	0.61%
0.81%	Geode Capital Management, LLC	421,710	US$535.6k	-2.55%	no data
0.79%	Arnold Levine	409,842	US$520.5k	0%	no data
0.77%	Wilmington Trust Investment Advisors, Inc.	399,548	US$507.4k	0%	0.01%
0.73%	Oppenheimer Asset Management Inc.	380,599	US$483.4k	0%	no data
0.71%	Connor, Clark & Lunn Investment Management Ltd.	370,920	US$471.1k	-15.9%	no data
0.62%	Baker Bros. Advisors LP	322,024	US$409.0k	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/03/23 23:08
End of Day Share Price	2025/03/21 00:00
Earnings	2024/12/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

PMV Pharmaceuticals, Inc. is covered by 10 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Gregory Harrison	BofA Global Research
Gum-Ming Lowe	Craig-Hallum Capital Group LLC
Joshua Schimmer	Evercore ISI